Pulmonx Corp Stockholders Equity

Quick Answer

Pulmonx Corp reported Stockholders Equity of $54.12 million for fiscal year 2025.

Pulmonx Corp Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $54.12M -36.9%
2024 $85.81M -27.5%
2023 $118.31M -23.2%
2022 $154.01M -20.3%
2021 $193.24M -14.5%
2020 $226.13M +220.7%
2019 -$187.38M -12.0%
2018 -$167.33M -12.0%
2017 -$149.39M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $60.03M -36.1% -13.1%
June 30, 2025 $69.09M -31.7% -11.0%
March 31, 2025 $77.67M -29.7% -9.5%
December 31, 2024 $85.81M -27.5% -8.6%
September 30, 2024 $93.92M -25.3% -7.2%
June 30, 2024 $101.18M -24.5% -8.4%
March 31, 2024 $110.50M -23.2% -6.6%
December 31, 2023 $118.31M -23.2% -5.9%
  • Pulmonx Corp showed a decrease of -36.9% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2017–2025 period, Pulmonx Corp’s stockholders equity has grown by 136.2% (from -$149.39 million to $54.12 million).
  • The most recent figure is from Pulmonx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment